World News

FDA Approves Elacestrant for ER-positive, HER2-negative, ESR1-mutated Advanced or Metastatic Breast...

Ogkologos - 7 Φεβρουαρίου, 2023

The ‘major conditions strategy’: will ministers fail to give cancer the...

Ogkologos - 6 Φεβρουαρίου, 2023

A Large Genomic Analysis Identifies That Persistent Tumour Mutational Burden Is...

Ogkologos - 6 Φεβρουαρίου, 2023

4 Steps We Can All Take on World Cancer Day to...

Ogkologos - 3 Φεβρουαρίου, 2023

Tesco is making it even easier to support life-saving research

Ogkologos - 3 Φεβρουαρίου, 2023

World Cancer Day 2023: where does the UK stand?

Ogkologos - 3 Φεβρουαρίου, 2023

Cooperativity of BRAF/MAPK Pathway Inhibition and Immune Checkpoint Blockade in Patients...

Ogkologos - 3 Φεβρουαρίου, 2023

Cancer in My Community: The 3 Ways People Access Cancer Care...

Ogkologos - 2 Φεβρουαρίου, 2023

Help Desk for Oncologists Treating People with a Rare Leukemia Pays...

Ogkologos - 2 Φεβρουαρίου, 2023

FDA Approves Pembrolizumab as Adjuvant Treatment for NSCLC

Ogkologos - 2 Φεβρουαρίου, 2023

1...150151152...432 Σελίδα 151 από 432

MOST POPULAR

Durable Antitumour Activity of Pembrolizumab Plus Lenvatinib in Patients with Previously...

25 Ιουλίου, 2023

Meeting Cancer Survivors’ Psychosocial Health Needs: A Conversation with Dr. Patricia...

7 Ιουνίου, 2022

Study Finds Accelerated Partial-Breast Radiation Just as Effective as Whole Breast...

13 Δεκεμβρίου, 2019

Enhancements to NCI’s SEER Program Creating New Research Opportunities

23 Αυγούστου, 2018

Φόρτωση περισσοτέρων

FDA Approves Elacestrant for ER-positive, HER2-negative, ESR1-mutated Advanced or Metastatic Breast...

The ‘major conditions strategy’: will ministers fail to give cancer the...

A Large Genomic Analysis Identifies That Persistent Tumour Mutational Burden Is...

4 Steps We Can All Take on World Cancer Day to...

Tesco is making it even easier to support life-saving research

World Cancer Day 2023: where does the UK stand?

Cooperativity of BRAF/MAPK Pathway Inhibition and Immune Checkpoint Blockade in Patients...

Cancer in My Community: The 3 Ways People Access Cancer Care...

Help Desk for Oncologists Treating People with a Rare Leukemia Pays...

FDA Approves Pembrolizumab as Adjuvant Treatment for NSCLC

MOST POPULAR

Durable Antitumour Activity of Pembrolizumab Plus Lenvatinib in Patients with Previously...

Meeting Cancer Survivors’ Psychosocial Health Needs: A Conversation with Dr. Patricia...

Study Finds Accelerated Partial-Breast Radiation Just as Effective as Whole Breast...

Enhancements to NCI’s SEER Program Creating New Research Opportunities

HOT NEWS

¿Cómo están cambiando los requisitos de elegibilidad para los ensayos clínicos...

Uveal Melanoma: ESMO–EURACAN Clinical Practice Guideline

Neoadjuvant Nivolumab Plus Chemotherapy Results in Significantly Longer Event-Free Survival in...

Electronic Symptom Monitoring with PROs Improves Patient-Reported Physical Function, Symptom Control,...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ